Exelixis Market Cap

Exelixis has a market cap or net worth of $11.86 billion as of January 9, 2026. Its market cap has increased by 24.00% in one year.

Market Cap

11.86B

Enterprise Value

10.47B

1-Year Change

24.00%

Ranking

#859

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $11.86B, an increase of 1,779.47%. That is a compound annual growth rate of 12.07%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	11.81B	0.48%
Dec 31, 2025	11.75B	23.57%
Dec 31, 2024	9.51B	27.47%
Dec 29, 2023	7.46B	44.19%
Dec 30, 2022	5.17B	-10.54%
Dec 31, 2021	5.78B	-7.11%
Dec 31, 2020	6.23B	16.30%
Dec 31, 2019	5.35B	-8.96%
Dec 31, 2018	5.88B	-34.61%
Dec 29, 2017	8.99B	110.58%
Dec 30, 2016	4.27B	233.29%
Dec 31, 2015	1.28B	355.89%
Dec 31, 2014	281.10M	-75.11%
Dec 31, 2013	1.13B	34.59%
Dec 31, 2012	839.00M	36.62%
Dec 30, 2011	614.10M	-31.37%
Dec 31, 2010	894.80M	13.07%
Dec 31, 2009	791.40M	49.29%
Dec 31, 2008	530.10M	-41.23%
Dec 31, 2007	902.00M	4.64%
Dec 29, 2006	862.00M	10.08%
Dec 30, 2005	783.10M	10.19%
Dec 31, 2004	710.70M	41.83%
Dec 31, 2003	501.10M	9.05%
Dec 31, 2002	459.50M	-44.16%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.29B
Johnson & Johnson	492.44B
AbbVie	388.97B
UnitedHealth Group	311.59B
AstraZeneca	295.57B
Merck & Co.	274.34B
Novartis AG	272.98B
Novo Nordisk	263.81B

Market Cap Rankings